Short-term light sedation with remimazolam besylate versus propofol in the ICU (SHOSREB): a multicentre, randomized, single-blind, controlled trial.
Yang X, Pan J, Gong X, Lv A, Liang F, Liu J, Li D, Fu S, Pan A, Yu L, Zhang L, Chen T, Zhan L, Qin B, Lin F, Xiong X, Zhu Y, He Z, Sun R, Sun T, Qian S, Wen D, Zou X, Qi H, Shu H, Song L, Wang C, Shang Y.
Yang X, et al. Among authors: chen t.
Intensive Care Med. 2026 May;52(5):1001-1011. doi: 10.1007/s00134-026-08381-x. Epub 2026 Mar 31.
Intensive Care Med. 2026.
PMID: 41915173
Clinical Trial.